Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...
More Data Suggests 'Ultraprocessed' Foods Can Shorten Your Life
People who eat large amounts of ultra-processed foods have a slightly higher risk of premature death than those who mostly shun the industrially produced...
Colon Cancer Cases Rising Sharply Among Children, Teens
Colon cancer steadily increased among young people in the United States over the past two decades, with tweens enduring the most dramatic leap in cancer...
Eating Disorders Common in People With Type 1 Diabetes
One in every four people age 16 or older with type 1 diabetes may be struggling with an eating disorder, a new review of data on the subject finds.Type...
Can Zinc Really Shorten a Cold?
Every cold and flu season, folks are flooded with ads for zinc lozenges, sprays and syrups that promise to shorten their sniffles.Zinc might indeed reduce...
321,566 Children Lost a Parent to Drug Overdose in 2011 to 2021
From 2011 to 2021, an estimated 321,566 children lost a parent to drug overdose in the United States, according to a study published online May 8 in JAMA...
Majority of U.S. Adults Give Health Care System a 'D' for Handling Mental Health
Three-quarters of U.S. adults believe mental health issues are identified and treated worse than physical health issues, according to the results of a...
Distal Symmetric Polyneuropathy Often Undiagnosed
Distal symmetric polyneuropathy (DSP) is common and is frequently undiagnosed, according to a study published online May 8 in Neurology.Melissa A. Elafros,...
Procedure Risk Tied to Outcomes in Older Emergency General Surgery Patients
Procedure risk is more strongly associated with outcomes in older patients undergoing emergency general surgery than assessing frailty, according to a...
There's a New Set of COVID Variants Called FLiRT: What You Need to Know
The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported. The...
Bayer to Unveil Late-Breaking Data from Phase III OASIS 1 and 2 for Elinzanetant in the Treatment of Vasomotor Symptoms Associated with Menopause
Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound...
Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid Use Disorder Shown Effective
Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...